Invention Grant
- Patent Title: Rapamycin resistant cells
-
Application No.: US17049782Application Date: 2019-04-25
-
Publication No.: US11987804B2Publication Date: 2024-05-21
- Inventor: Andrew M. Scharenberg , David J. Rawlings , Karen Sommer , Samuel West , Yuchi Chiang Honaker , Ryo Takeuchi
- Applicant: Seattle Children's Hospital
- Applicant Address: US WA Seattle
- Assignee: Seattle Children's Hospital
- Current Assignee: Seattle Children's Hospital
- Current Assignee Address: US WA Seattle
- Agency: Knobbe, Martens, Olson & Bear LLP
- International Application: PCT/US2019/029118 2019.04.25
- International Announcement: WO2019/210057A 2019.10.31
- Date entered country: 2020-10-22
- Main IPC: C12N15/90
- IPC: C12N15/90 ; C07K14/715 ; C12N15/113 ; C12N15/86

Abstract:
The present application relates to, inter alia, compositions including proteins for expression in host cells to render them resistant to rapamycin. The application further relates to methods of using the proteins, cells, and compositions disclosed therein for modulating cell signaling and for selective expansion of cells.
Public/Granted literature
- US20210340573A1 RAPAMYCIN RESISTANT CELLS Public/Granted day:2021-11-04
Information query
IPC分类: